• Product Description:

Entecavir, a guanosine nucleoside analogue with activity against HBV reverse transcriptase.
Entecavir inhibits all three activities of the HBV reverse transcriptase: (1) base priming, (2) reverse transcription of the negative strand from the pregenomic messenger RNA, and (3) synthesis of the positive strand of HBV DNA.

  • Product Features:

Product Name IRETAVIR 0.5
Generic Name Entecavir USP 0.5 mg
FDA Approved Indications Entecavir is indicated for the treatment of chronic hepatitis B virus infection in adults with evidence of active viral replication and either evidence of persistent elevations in serum aminotransferases (ALT or AST) or histologically active disease.
Packaging IRETAVIR 0.5 mg tablets are supplied in alu alu blister. Each commercial box IRETAVIR contain 10’s (1X10’s) in alu- alu blister.